CorMedix Inc (NASDAQ:CRMD) Receives $15.00 Average Target Price from Analysts
Shares of CorMedix Inc (NASDAQ:CRMD – Get Free Report) have been assigned an average rating of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average […]
